Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...

Science Daily reserves all rights in and to any Science Daily logos, trademarks or trade names contained in any RSS feed, and your right to use these Science Daily logos, trademarks or trade names ...

Bill Gates predicted that advancements in artificial intelligence will significantly reduce humanity’s role in many ...

The best tech products announced this week include Klipsch's reimagined Heritage loudspeakers, Pro-Ject's automatic turntable ...

Catch up on the political news of the past week in the latest At the Races newsletter, including special elections and repeat ...

Christina McKelvie's partner, Keith Brown, along with her sons, Lewis and Jack, are deeply saddened to announce her passing.

In the corners of social media dominated by wellness content, influencers recommend an assortment of treatments and products ...

Markets have proven highly volatile in the first two months of President Trump’s new term of office, as investors are worried ...

2-Year U.S. Treasury Note Continuous Contract $103.594 0.059 0.06% 5-Year U.S. Treasury Note Continuous Contract $108.164 0.148 0.14% 10-Year U.S. Treasury Note Continuous Contract $111.359 0.188 ...

Apnimed, Inc., a pharmaceutical company focused on discovering, developing, and commercializing first-in-class oral therapies for the neuromuscular dysfunction associated with obstructive sleep apnea ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

Global gaming company Gravity has officially launched the mobile version of its new roguelike deck-building adventure game, ...